Literature DB >> 6648863

Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.

A J Williams, M S Baghat, D E Stableforth, R M Cayton, P M Shenoi, C Skinner.   

Abstract

Nine of 14 asthmatic patients who presented with persistent dysphonia while taking inhaled corticosteroids had a bilateral adductor vocal cord deformity with bowing of the cords on phonation. This causes the dysphonia and usually occurs without candidiasis. It was seen with beclomethasone dipropionate (in both pressurised aerosol and dry powder preparations), betamethasone valerate, and budesonide. It was related to the dose and potency of inhaled steroid and may represent a local steroid myopathy. It was reversed when the inhaled steroid was stopped, although resolution sometimes took weeks. Laryngeal candidiasis may have contributed to the vocal cord abnormality in two of these nine patients. Of the five patients without vocal cord deformity, laryngeal candidiasis was the sole cause of dysphonia in three. In the remaining two dysphonia was thought to be psychogenic. The vocal cord deformity may exist subclinically. Of nine patients who started to take aerosol steroid and who were examined monthly for one year, three developed vocal cord deformity but only one had persistent dysphonia. Vocal abuse did not appear to contribute to dysphonia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648863      PMCID: PMC459669          DOI: 10.1136/thx.38.11.813

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing.

Authors:  M B Dolovich; D Killian; R K Wolff; G Obminski; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1977-03

2.  Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Preliminary report of the Brompton Hospital-Medical Research Council Collaborative Trial.

Authors: 
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

3.  Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma.

Authors:  J Gaddie; G R Petrie; I W Reid; C Skinner; D J Sinclair; K N Palmer
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

4.  Aerosol beclomethasone dipropionate in chronic bronchial asthma.

Authors:  J Gaddie; I W Reid; C Skinner; G R Petrie; D J Sinclair; K N Palmer
Journal:  Lancet       Date:  1973-03-31       Impact factor: 79.321

5.  Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma.

Authors:  T J Clark
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

6.  Incidence of candida in hospital in-patients and the effects of antibiotic therapy.

Authors:  B J Smits; A P Prior; P G Arblaster
Journal:  Br Med J       Date:  1966-01-22

7.  Pharmacokinetics of inhaled substances.

Authors:  D S Davies
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

8.  Beclomethasone dipropionate aerosol and oropharyngeal candidiasis.

Authors:  R F Willey; L J Milne; G K Crompton; I W Grant
Journal:  Br J Dis Chest       Date:  1976-01

9.  Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment.

Authors:  M K McAllen; S J Kochanowski; K M Shaw
Journal:  Br Med J       Date:  1974-02-02

10.  Beclomethasone dipropionate and oropharyngeal candidiasis.

Authors:  L J Milne; G K Crompton
Journal:  Br Med J       Date:  1974-09-28
View more
  23 in total

1.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

Review 2.  Practical considerations for dysphonia caused by inhaled corticosteroids.

Authors:  César A Galván; Juan Carlos Guarderas
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

3.  Osteogenesis imperfecta in the differential diagnosis of child abuse.

Authors:  C R Paterson; S J McAllion
Journal:  BMJ       Date:  1989-12-09

Review 4.  Adverse effects of inhaled corticosteroids.

Authors:  R J Stead; N J Cooke
Journal:  BMJ       Date:  1989-02-18

5.  Association between asthma and risk of developing obstructive sleep apnea.

Authors:  Mihaela Teodorescu; Jodi H Barnet; Erika W Hagen; Mari Palta; Terry B Young; Paul E Peppard
Journal:  JAMA       Date:  2015-01-13       Impact factor: 56.272

Review 6.  The place of high-dose inhaled corticosteroids in asthma therapy.

Authors:  M J Smith
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

Review 7.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 8.  Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

9.  Evaluation of laryngeal findings in users of inhaled steroids.

Authors:  Gul Ozbilen Acar; Nurten Uzun Adatepe; Asim Kaytaz; Deniz Tuna Edizer; Bilun Gemicioglu; Cengiz Yagiz; Ahmet Dirican
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-12       Impact factor: 2.503

Review 10.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.